REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc. (Nasdaq: REVB) is a clinical-stage biotechnology company focused on immunology and the development of therapeutic and diagnostic candidates for infectious diseases. The company filed a Form 8-A12B with the SEC on July 13, 2026, registering a class of its securities on a national securities exchange — a step that typically accompanies an exchange listing or the closing of a business combination in the life sciences sector. REVB operates within the healthcare and biotechnology industry, an active vertical for SPAC-related transactions in recent years. Sign up at SpacDesk for full filing history, deal timelines, sponsor profiles, and real-time alerts on REVB and the broader SPAC universe.